Clinical Psychopharmacology · Paper A
Lithium toxicity and monitoring
Lithium has a narrow therapeutic indexThe gap between a drug's effective dose and its toxic dose; a narrow one means less room for error.Read more → (0.6-1.0 mmol/L), meaning the gap between an effective dose and a toxic one is small, so anything that raises its blood level can tip a stable patient into toxicity. A patient on stable lithium who starts ibuprofen for a headache can develop a coarse tremor and unsteady walking within days. Any new drug or illness that changes fluid or sodium balance needs a lithium level check, not just a dose review.
Lithium is excreted by the kidney and handled like sodium, so dehydration, sodium depletion, NSAIDs (anti-inflammatory painkillers), ACE inhibitors, ARBs and thiazide diuretics all reduce its clearanceThe rate at which the body removes a drug from the blood.Read more → and can precipitate toxicity. Early toxicity, above 1.5 mmol/L, gives a coarse tremor, ataxiaLoss of full control of body movements, causing an unsteady, uncoordinated gait or actions.Read more → (unsteady, clumsy movement), dysarthria (slurred speech), vomiting and drowsiness. Severe toxicity, above 2.0 mmol/L, gives seizures, renal failure and coma. A patient started on a thiazide diuretic for blood pressure without a lithium level check can see levels climb from therapeutic into the toxic range within days, e.g. a routine cardiology prescription turning into a psychiatric emergency. Clinically, a lithium level should be checked before starting any of these interacting drugs, not only once toxicity symptoms have already appeared.
A fresh doctor might treat lithium like most drugs, where a missed level check now and then is a minor omission. Lithium's narrow (0.6-1.0 mmol/L, the gap between a dose that works and a dose that poisons) makes routine monitoring the actual treatment, not paperwork around it. Hold the phrase NARROW MARGIN through every section below, because nearly every fact here traces back to how little room lithium leaves for error.
Lithium is a mood stabiliser used mainly for bipolar disorder (episodes of and depression) and as an add-on for treatment-resistant depression. Unlike most psychiatric drugs, its effective dose and its toxic dose sit close together, so the same blood investigation used to confirm a therapeutic level is also the test that catches early toxicity. TOXICITY here means a serum lithium concentration that has climbed high enough to cause harm, not simply "too much medication" in a loose sense; diagnosis rests on that investigation plus the clinical picture together, not the level alone.
A common mistake is assuming lithium toxicity only happens with an overdose or a prescribing error. In fact, most toxicity in clinical exams and on real wards happens in a patient on a previously stable, correct dose who develops an intercurrent illness or starts an interacting drug. The NARROW MARGIN means the dose was never the whole story: is.
Consider a patient stable on lithium for years who develops a bad bout of vomiting and diarrhoea from gastroenteritis. Nothing about their prescription changed, yet within days they could be in toxicity. That is because lithium is excreted almost entirely by the kidney and handled by the body much like sodium: anything that reduces renal blood flow, sodium levels, or fluid volume (dehydration, vomiting, diarrhoea, a hot climate, reduced fluid intake) reduces lithium and lets it accumulate. This is the single mechanism behind almost every precipitant of toxicity discussed below.
NSAIDs (non-steroidal anti-inflammatory drugs, common over-the-counter painkillers such as ibuprofen), ACE inhibitors and ARBs (angiotensin-receptor blockers, both used for blood pressure and heart failure), and thiazide diuretics (a class of "water tablet") all reduce renal of lithium through different actions on the kidney, and all can precipitate toxicity even without any change to the lithium dose itself. A patient started on a thiazide for blood pressure, or one who buys ibuprofen over the counter for a headache, is at real risk if nobody checks a lithium level first. This is why lithium is one of the few drugs where a prescriber must actively think about every other medicine a patient starts.
, from combining drugs, causes and and typically comes on faster after a specific drug change, unlike the gradual accumulation seen in lithium toxicity. Nephrogenic diabetes insipidus, a long-term consequence of lithium therapy itself (the kidney loses its ability to concentrate urine, causing chronic excess thirst and urination), is a separate, chronic complication rather than the acute picture of toxicity. Ordinary therapeutic-level side effects (fine tremor, mild nausea, modest weight gain) should not be mistaken for the coarse tremor and confusion of true toxicity.
Diagnosis is made on a serum lithium level combined with the clinical picture, never the level alone. Early (mild-to-moderate) toxicity presents with a coarse tremor (a large, obvious shake, distinct from the fine tremor seen at normal therapeutic levels), gastrointestinal upset (nausea, vomiting, diarrhoea), and (unsteady, uncoordinated walking or movement). As levels rise further, severe toxicity produces confusion, dysarthria (slurred speech), seizures, and eventually renal failure and coma. The distinction between a fine tremor (normal, therapeutic-level side effect) and a coarse tremor (a toxicity warning sign) is one of the most tested discriminators in this topic, and a level should always be checked whenever that clinical picture appears rather than being assumed from the dose on the prescription chart.
Monitoring is a serum lithium level taken 12 hours post-dose, checked initially weekly during titration, then every three months once stable, alongside renal function screening, thyroid function, and calcium, because lithium can also cause hypothyroidism (an underactive thyroid) and, less commonly, hyperparathyroidism over long-term use. Mild-to-moderate toxicity is managed with fluid resuscitation and stopping the drug; severe toxicity, particularly with very high levels, renal failure, or a deteriorating conscious level, may need haemodialysis (a machine that filters the blood when the kidneys cannot). Any prescriber starting an NSAID, ACE inhibitor/ARB, or thiazide diuretic in a patient on lithium should check a level rather than waiting for symptoms: this monitoring-first approach, reflected in Maudsley Prescribing Guidelines and BNF advice, is the actual treatment for a drug this narrow, not an optional add-on to it.
Vignettes often describe a patient recently started on a thiazide diuretic or an NSAID who then develops a coarse tremor and vomiting: the expected answer is lithium toxicity from reduced renal , not a new unrelated illness. A further trap tests whether candidates know the level should be taken 12 hours post-dose, since a level taken at the wrong time is uninterpretable and can wrongly suggest toxicity, or wrongly reassure, either way.
Lithium's narrow means dehydration, NSAIDs, ACE inhibitors/ARBs, thiazide diuretics, and renal impairment can all precipitate toxicity (coarse tremor, vomiting, , then confusion and seizures) without any change in prescribed dose, which is exactly why scheduled 12-hour post-dose monitoring is the real safeguard, not the dose itself.